Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
Phathom Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 13, 2023
Phathom Pharmaceuticals reported fiscal year 2022 executive compensation information on April 13, 2023.
In 2022, three executives at Phathom Pharmaceuticals received on average a compensation package of $3.5M, a 34% decrease compared to previous year.
Average pay of disclosed executives at Phathom Pharmaceuticals
Terrie Curran, Chief Executive Officer, received $5M in total, which decreased by 20% compared to 2021. 78% of Curran's compensation, or $3.9M, was in option awards. Curran also received $442K in non-equity incentive plan, $650K in salary, as well as $15K in other compensation.
Azmi Nabulsi, Chief Operating Officer, received a compensation package of $2.8M, which decreased by 36% compared to previous year. 70% of the compensation package, or $1.9M, was in option awards.
Molly Henderson, Chief Accounting Officer, earned $2.6M in 2022.
Related executives
You may also like
Source: SEC filing on April 13, 2023.